drugset / Trial / NCT05611957
A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The main purpose of this study is to assess the amount of study drug that reaches the bloodstream and the time it takes for the body to get rid of it when given to participants with renal (kidney) impairment compared to healthy participants. The study will last up to 5 weeks, excluding screening.
Timeline
- Start
- 2022-11-16
- Primary completion
- 2023-09-05
- Completion
- 2023-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Retatrutide | Protein / enzyme biologic | — | Subcutaneous |